Company Overview of Revalesio Corporation
Revalesio Corporation, a biotechnology company, develops therapeutics for the treatment of inflammatory diseases. It offers respiratory, cardiovascular, neuroscience, orthopedic, wound care, and oncology products. The company was formerly known as Microdiffusion, Inc. and changed its name to Revalesio Corporation in August 2007. Revalesio Corporation was founded in 2000 and is based in Tacoma, Washington.
1200 East D Street
Tacoma, WA 98421
Founded in 2000
Key Executives for Revalesio Corporation
Similar Private Companies By Industry
|21st Century Animal Health||United States|
|3 Buds' Organics LLC||United States|
|4P Therapeutics LLC||United States|
|60° Pharmaceuticals, LLC||United States|
|7 Oaks Pharmaceutical Corp.||United States|
Recent Private Companies Transactions
June 23, 2016
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|Bloomberg L.P.||United States|
|NYC2012, Inc.||United States|
|The Advertising Council, Inc.||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Revalesio Corporation, please visit revalesio.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.